1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drug-Induced Cardiovascular Disease

Drug-Induced Cardiovascular Disease

151 - 165 of 169 Results
Sort Results:
Commentary: Levothyroxine: Are the Elderly Overtreated? July 2011
Other: FDA listing of Unapproved Prescription Cough, Cold, and Allergy Products April 2011
Chart: Alternatives to Unapproved Cough and Cold Meds April 2011
Commentary: Propoxyphene Withdrawal from the Market January 2011
Patient Education: Propoxyphene Withdrawn from the Market January 2011
Patient Education: Avandia and Risk of Heart Attack August 2010
Other: SAMPLE Informed Consent Form for Quinine from Prescriber's Letter June 2010
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes December 2008
Commentary: Updated Treatment Recommendations for Type 2 Diabetes December 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008
Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008
Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Commentary: NSAID Use in Patients with Unstable Angina or Myocardial Infarction February 2008